Actively Recruiting

Phase Not Applicable
Age: 10Years - 110Years
All Genders
Healthy Volunteers
NCT06230198

The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery

Led by Population Health Research Institute · Updated on 2025-03-04

4500

Participants Needed

4

Research Sites

99 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The TheRAPy vanguard trial is a multicentre, multiple period randomized, cluster crossover vanguard trial testing the feasibility of a full-scale trial to evaluate whether a centre-based policy of routine use of RAP versus a policy of crystalloid priming reduces RBC transfusion for patients undergoing cardiac surgery on cardiopulmonary bypass. It will also provide information about key parameters of the TheRAPy full-scale trial.

CONDITIONS

Official Title

The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery

Who Can Participate

Age: 10Years - 110Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Hospitals completing >200 adult cardiac surgical cases a year
  • At least 95% of the cardiovascular surgery group agrees to manage patients under both autologous priming policies as per the randomization schedule
  • All patients undergoing cardiac surgery on cardiopulmonary bypass at an enrolled site during the trial period will be included in data collection
Not Eligible

You will not qualify if you...

  • Hospitals completing ≤200 cardiac surgical cases
  • Less than 95% of the cardiovascular surgery group agrees to manage patients according to either of the two policies

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

St. Boniface Hospital

Winnipeg, Manitoba, Canada, R2H 2A6

Actively Recruiting

2

Hamilton General Hospital

Hamilton, Ontario, Canada, L8S 48L

Actively Recruiting

3

Montreal Heart Institute

Montreal, Quebec, Canada, H1T 1C8

Actively Recruiting

4

Centre Hospitalier de l'Université de Montréal (CHUM)

Montreal, Quebec, Canada, H2X 0A9

Actively Recruiting

Loading map...

Research Team

T

TheRAPy Study Coordinator

CONTACT

J

Jessica Spence

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery | DecenTrialz